|
Redwood City, CA – June 20,
2007 – Ingenuity Systems, the
leading provider of information
solutions for the exploration, interpretation,
and analysis of experimental data for life
sciences
researchers, today announced that it has been
awarded a new, five-year contract with
Integromics, one of the foremost life science
IT companies in Spain and the service provider
to
the Genomics, Proteomics and Bioinformatics
Core Facility of Andalusia (Málaga,
Spain).
Ingenuity Systems was selected by Integromics
to be its sole pathways analysis provider,
enabling the Andalusian Core Facility and
all of its academic member organizations to
use
Ingenuity Pathways Analysis (IPA).
The Andalusian Core Facility provides scientists
in public research institutions access to
a
powerful bioinformatic core infrastructure
formed by supercomputing hardware facilities
and
state-of-the-art software. Integromics provides
sophisticated software solutions for data
management and data analysis in genomics,
proteomics, and drug discovery. From its scientific
base, Integromics offers its clients a deep
and current understanding of challenges, initiatives,
and solutions related to life sciences. Integromics
has formed important partnerships in industry
and academia to develop technological solutions
that enable clients to achieve their goals.
Integromics is headquartered at the Business
Entrepreneur Facilities for Life Sciences
of Granada,
Spain. www.integromics.com
"Ingenuity Systems was selected because
they offer the most comprehensive pathways
solution,
with the most extensive biological and chemical
knowledge. IPA provides a great
complementarity with other tools for functional
analysis of genomic data like Integromic’s
ArrayUnlock©. Additionally, IPA provides
a remarkable add-on to our portfolio in secondary
analysis as it is integrated with our Spotfire
DecisionSite® modules for microarray analysis,”
commented Pedro A. de Alarcon, Business Development
Director of Integromics.
"We are very pleased to have been selected
by Integromics to support such a progressive
initiative," stated Brian Dron, Director
of European Operations at Ingenuity Systems.
"We have
earned the confidence of life science researchers
through our commitment to quality, usability,
and innovation. We are excited to expand our
efforts in Spain by delivering these capabilities
to
support research groups in genomics, proteomics
and drug discovery.”
Ingenuity Pathways Analysis 5.0 is a software
and knowledgebase application that enables
researchers to model, analyze, and understand
the complex biological and chemical systems
at
the core of life science research. IPA is
deployed in all major pharmaceutical companies
and in
hundreds of biotechnology companies and academic
institutions globally. It supports analysis
of
data from all experimental platforms, and
is used at all stages of the drug discovery
and
development process, including target identification
and validation, identification of biomarkers,
predictive toxicology, and pharmacogenomics.
Trials of Ingenuity Pathways Analysis 5.0
are currently being offered at http://www.ingenuity.com/trial.
For more information about Ingenuity Pathways
Analysis 5.0, please email sales@ingenuity.com
or go to www.ingenuity.com.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze,
and understand complex biological and chemical
systems foundational to human health and disease.
The Ingenuity products include pathways analysis
software and knowledge bases for life scientists
and bioinformaticians, and enterprise knowledge
management infrastructure, content and services
for leading pharmaceutical and biotech companies.
Ingenuity was founded in 1998 and is headquartered
in Redwood City, California, with offices in
Germany, Switzerland, France, the United Kingdom,
and Japan. www.ingenuity.com.
About Integromics, SL®
Integromics provides innovative IT solutions
for Life Sciences (Genomics and Proteomics).
In the
post-genomic era, Integromics offers state-of-the-art
products, services and training in two
strategic areas: data management/integration
and intelligent data analysis. The company has
developed a network of collaborations both in
the industry (Applied Biosystems, Spotfire Inc)
and academia to supply complete technological
solutions that will facilitate our clients the
achievement of their goals. Integromics, SL
was founded in 2002 and it is based in Granada,
Spain, having offices in Madrid (Spain), Philadelphia
(USA) and Russe (Bulgaria). For more information:
www.integromics.com.
Contact:
Heidi Bullock
Director, Marketing
Ingenuity Systems
650.381.5150
Pedro A. de Alarcon
Business Development & Marketing Director
+34 958 750 627
>
View as PDF 
|
